Choroidal neovascular membrane complicating traumatic choroidal rupture managed by intravitreal bevacizumab.
Yadav
N K
NK
Bharghav
M
M
Vasudha
K
K
Shetty
K B
KB
D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D002829:Choroid / Q000293:injuries*; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D016489:Head Injuries, Closed / Q000150:complications; D006801:Humans; D058449:Intravitreal Injections; D016896:Treatment Outcome
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab